These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

893 related items for PubMed ID: 15492353

  • 1. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 2. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G, Cosenza A, Mucci M, Brovedani P.
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [Abstract] [Full Text] [Related]

  • 3. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.
    McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):685-93. PubMed ID: 9136504
    [Abstract] [Full Text] [Related]

  • 4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A, Binder C, Snyder R, Fisman S.
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [Abstract] [Full Text] [Related]

  • 6. Role of risperidone in children with autism spectrum disorder.
    Chavez B, Chavez-Brown M, Rey JA.
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [Abstract] [Full Text] [Related]

  • 7. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
    Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E.
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1443-50. PubMed ID: 14627879
    [Abstract] [Full Text] [Related]

  • 8. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):32-6. PubMed ID: 19772883
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
    Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, Risperidone Disruptive Behavior Study Group.
    Am J Psychiatry; 2002 Aug 01; 159(8):1337-46. PubMed ID: 12153826
    [Abstract] [Full Text] [Related]

  • 10. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Greenspan A.
    Int J Geriatr Psychiatry; 2005 Dec 01; 20(12):1153-7. PubMed ID: 16315159
    [Abstract] [Full Text] [Related]

  • 11. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov 01; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 12. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.
    Bipolar Disord; 2009 Nov 01; 11(7):687-700. PubMed ID: 19839994
    [Abstract] [Full Text] [Related]

  • 13. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.
    J Clin Pharm Ther; 2004 Apr 01; 29(2):145-50. PubMed ID: 15068403
    [Abstract] [Full Text] [Related]

  • 14. Risperidone and cognitive function in children with disruptive behavior disorders.
    Pandina GJ, Bilder R, Harvey PD, Keefe RS, Aman MG, Gharabawi G.
    Biol Psychiatry; 2007 Aug 01; 62(3):226-34. PubMed ID: 17210137
    [Abstract] [Full Text] [Related]

  • 15. Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.
    Croonenberghs J, Fegert JM, Findling RL, De Smedt G, Van Dongen S, Risperidone Disruptive Behavior Study Group.
    J Am Acad Child Adolesc Psychiatry; 2005 Jan 01; 44(1):64-72. PubMed ID: 15608545
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May 01; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA, McDougle CJ.
    Child Adolesc Psychiatr Clin N Am; 2008 Oct 01; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL.
    Pediatrics; 2009 Dec 01; 124(6):1533-40. PubMed ID: 19948625
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
    Pediatrics; 2005 Dec 01; 116(6):e777-84. PubMed ID: 16322134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.